Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Egalet Corp (NQ: EGLT )

N/A USD UNCHANGED
Last Price Updated: 7:37 PM EDT, Sep 18, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.3100 (7)
Ask (Size) 0.3300 (300)
Prev. Close 0.3273
Today's Range 0.3273 - 0.3273
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Egalet Reports Third Quarter 2018 Financial Results
-- Highest quarterly revenue for SPRIX Nasal Spray and OXAYDO -- 
From PR Newswire
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
--Anticipates projected pro forma annual net revenue of between $80 and $90 million-- 
From PR Newswire

Performance

More News

Read More
New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, Hertz Global, and ACADIA Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations fo
From GlobeNewswire News Releases
Egalet Reports Second Quarter 2018 Financial Results
From PR Newswire
Market Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners — Emerging Consolidated Expectations, Analyst Ratings
From GlobeNewswire News Releases
Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018
From PR Newswire
Pre-Market Research Reports on Biotech Stocks -- Dermira, Dicerna Pharma, Egalet, and Eidos Therapeutics
From PR Newswire
Egalet Appoints Industry Veteran John Varian to Board of Directors
From PR Newswire
Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference
From PR Newswire
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
From PR Newswire
Report: Developing Opportunities within Integer, Sykes Enterprises, Protagonist Therapeutics, Egalet, Watsco, and Extra Space Storage — Future Expectations, Projections Moving into 2018
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback